SPOTLIGHT -
Dr. Iagaru on Advancements in PSMA-PET Imaging for Prostate Cancer
Andrei H. Iagaru, MD, discusses key points from his presentation on the use of novel vs conventional imaging to manage metastatic hormone-sensitive prostate cancer.
Read More
Darolutamide Demonstrates Activity, Safety in AR-Positive Salivary Gland Cancer
Lenvatinib Plus Pembrolizumab Maintains Survival Benefit in Advanced ccRCC
Enfortumab Vedotin Plus Pembrolizumab Produces Durable Responses, Safety in Metastatic Urothelial Carcinoma
Cabozantinib Plus Nivolumab/Ipilimumab Generates PFS and DCR in Metastatic Soft Tissue Sarcoma
